optomap® Procedures
optomap® Retinal Examinations (“optomap®”), provide eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina.
optomap®
Optos’ core product is the retinal image produced by the Panoramic200 Scanning Laser Ophthalmoscope device: the optomap® retinal image.
Optos has also developed two new retinal imaging products – optomap® plus Medical Retinal Exam and optomap® fa Dynamic Ultra-widefield Angiography.
Capturing an ultra-widefield optomap® retinal image (200 internal degree view) does not require pupil dilation. Certain ocular conditions or patient medical history may indicate that dilation is necessary when performing the optomap® Retinal Exam.
optomap® Retinal Examination
The
optomap® is the company’s core product. It is created using the Panoramic200 and is used in primary level eye care for the screening of eye and non-eye diseases and disorders. It is available on a pay-per-patient examination basis and is non-reimbursable. The
optomap® provides the practitioner with a digital wide-field of view of the patient’s retina which is viewed on-screen by the practitioner in the presence of the patient. As a digital image, an
optomap® can be used in telemedicine applications or can be printed to provide documentation for the patient’s file.
optomap® plus Medical Retinal Examination
The optomap® plus Medical Retinal Examination is also performed using the Panoramic200 and is used in secondary level care. It uses additional capabilities in the image capture and review process to facilitate diagnosis and documentation of previously detected pathology. In the United States, the optomap® plus is eligible for reimbursement by the patient's insurance carrier.
optomap® fa Dynamic Ultra-widefield Angiography
This is a secondary level care retinal imaging product designed to offer advanced diagnostic retinal imaging through the provision of wide-field fluorescein angiography.
Retinal imaging is used by optometrists and ophthalmologists to screen for and diagnose eye and non-eye diseases and forms part of a comprehensive eye examination process in the company’s existing markets. Optos believes that many indicators of systemic disease and precursors to eye conditions often exhibit first in the periphery of the retina. However, routine retinal examination methods provide only a limited, narrow-field view of the retina (typically up to 45 degrees, or about 5%) in a single capture. Conventional retinal examinations can therefore miss eye and non-eye disorders or diseases that may be present and can be evidenced in the periphery of the retina. To capture a greater percentage of the retina, either the patient's eye must be dilated, causing patient discomfort, or multiple images of the retina must be taken, at additional cost and time to the practitioner.